Bethany Mayer Sells 686 Shares of Astera Labs (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) Director Bethany Mayer sold 686 shares of the stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $395.04, for a total value of $270,997.44. Following the completion of the transaction, the director owned 5,550 shares in the company, valued at approximately $2,192,472. The trade was a 11.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Astera Labs Price Performance

ALAB opened at $391.74 on Friday. Astera Labs, Inc. has a fifty-two week low of $85.85 and a fifty-two week high of $440.99. The firm has a market capitalization of $67.15 billion, a PE ratio of 264.69, a P/E/G ratio of 4.50 and a beta of 3.95. The company’s 50-day moving average is $289.20 and its 200 day moving average is $196.09.

Astera Labs (NASDAQ:ALABGet Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the prior year, the company posted $0.33 earnings per share. Astera Labs’s revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current year.

Hedge Funds Weigh In On Astera Labs

A number of hedge funds have recently bought and sold shares of the company. Glenmede Trust Co. NA raised its stake in shares of Astera Labs by 2.7% in the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after purchasing an additional 51 shares during the last quarter. Lido Advisors LLC boosted its position in shares of Astera Labs by 0.5% during the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after buying an additional 57 shares during the last quarter. Perigon Wealth Management LLC increased its holdings in Astera Labs by 6.2% in the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after buying an additional 73 shares in the last quarter. Clearstead Advisors LLC increased its holdings in Astera Labs by 13.6% in the 3rd quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after buying an additional 76 shares in the last quarter. Finally, Sound Income Strategies LLC raised its position in Astera Labs by 9.2% in the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after buying an additional 76 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on ALAB shares. UBS Group began coverage on shares of Astera Labs in a research note on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 target price on the stock. Citigroup downgraded shares of Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday, May 26th. Loop Capital assumed coverage on Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 target price on the stock. Evercore restated an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a research report on Tuesday, May 19th. Finally, Weiss Ratings upgraded Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Twelve equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $254.75.

Check Out Our Latest Stock Analysis on Astera Labs

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Stories

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.